Progenics Pharmaceuticals and Shutterfly to Join S&P SmallCap 600

NEW YORK, Feb. 15, 2017 /PRNewswire/ -- Effective with this press release, S&P Dow Jones Indices will now reference index changes using an "effective at the open" date rather than an "after the close of trading" date which is current practice.

Progenics Pharmaceuticals Inc. (NASD: PGNX) will replace Calamos Asset Management Inc. (NASD: CLMS) in the S&P SmallCap 600 effective at the open of Tuesday, February 21. Calamos Asset Management is being taken private in a transaction expected to be completed soon pending final conditions.

Shutterfly Inc. (NASD: SFLY) will replace Vascular Solutions Inc. (NASD: VASC) in the S&P SmallCap 600 effective at the open of Tuesday, February 21. S&P MidCap 400 constituent Teleflex Inc. (NYSE:TFX) is acquiring Vascular Solutions in a transaction expected to be completed soon pending final conditions.

Progenics Pharmaceuticals develops medicines for oncology. Headquartered in Tarrytown, NY, the company will be added to the S&P SmallCap 600 GICS (Global Industry Classification Standard) Biotechnology Sub-Industry index.

Shutterfly manufactures and retails personalized products and services. Headquartered in Redwood City, CA, the company will be added to the S&P SmallCap 600 GICS Internet & Direct Marketing Retail Sub-Industry index.

Following is a summary of the changes:

For more information about S&P Dow Jones Indices, please visit www.spdji.com

ABOUT S&P DOW JONES INDICES

S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500^® and the Dow Jones Industrial Average^®. More assets are invested in products based on our indices than based on any other provider in the world. With over 1,000,000 indices and more than 120 years of experience constructing innovative and transparent solutions, S&P Dow Jones Indices defines the way investors measure and trade the markets.

S&P Dow Jones Indices is a division of S&P Global (NYSE: SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spdji.com.

FOR MORE INFORMATION:

Soogyung Jordan
Global Head of Communications
New York, USA
(+1) 212 438 2297
soogyung.jordan@spdji.com

David Blitzer
Managing Director and Chairman of the Index Committee
New York, USA
(+1) 212 438 3907
david.blitzer@spglobal.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/progenics-pharmaceuticals-and-shutterfly-to-join-sp-smallcap-600-300408455.html

SOURCE S&P Dow Jones Indices